Ultrasound-Accelerated Catheter-Directed Thrombolysis
- PMID: 37304917
- PMCID: PMC10257504
- DOI: 10.14740/cr1490
Ultrasound-Accelerated Catheter-Directed Thrombolysis
Abstract
Venous thromboembolism is a very common presentation in the hospital setting. In patients with high-risk pulmonary embolism (PE) or PE and hemodynamic instability, systemic thrombolytic treatment is generally indicated. In those with contraindications to systemic thrombolysis, catheter-directed local thrombolytic therapy and surgical embolectomy are currently considered. In particular, catheter-directed thrombolysis (CDT) is a drug delivery system coupling the endovascular drug administration nearby in the thrombus and the local facilitating effect of ultrasounds. The applications of CDT are currently debated. Here we provide a systematic review of the clinical utilization of CDT.
Keywords: Catheter-directed thrombolysis; Deep venous thrombosis; Embolectomy; Pulmonary embolism; Venous thromboembolism.
Copyright 2023, Alsamman et al.
Conflict of interest statement
The authors affirm that they have no conflict of interest.
References
-
- Notten P, de Smet A, Tick LW, van de Poel MHW, Wikkeling ORM, Vleming LJ, Koster A. et al. CAVA (Ultrasound-Accelerated Catheter-Directed Thrombolysis on Preventing Post-Thrombotic Syndrome) trial: long-term follow-up results. J Am Heart Assoc. 2021;10(11):e018973. doi: 10.1161/JAHA.120.018973. - DOI - PMC - PubMed